IL6 and breast carcinoma: ELISA revealed that the levels of cytokine IL6 in MG+4T1-CM and MG + MDA-MB-231-CM were significantly higher than those of cytokine IL6 in the MG or breast cancer cell group (P < 0.001, Figure 2B).